Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

Wang, WJ; Liu, ZH; Wang, K; Yu, HM; Cheng, YQ; Xiang, YJ; Feng, JK; Zhou, LP; Zhou, HK; Pan, WW; Guo, WX; Shi, J; Cheng, SQ

Cheng, SQ (通讯作者)，Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, 225 Changhai Rd, Shanghai 200433, Peoples R China.

CANCER MEDICINE, 2023; 12 (10): 11513

Abstract

Background: There is no consensus on the optimal regimen for unresectable recurrent hepatocellular carcinoma (HCC), so this retrospective study aimed ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索